Healthcare Decliners: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Brookdale Senior Living Inc. (NYSE:BKD), AAC Holdings, Inc. (NYSE:AAC), Mallinckrodt PLC (NYSE:MNK), Endologix Inc. (NASDAQ:ELGX)

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced that the pivotal TELESTAR Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome that is not adequately controlled by the current standard of care. Telotristat etiprate was discovered using Lexicon’s gene science, based on Nobel Prize-winning technology, and is the company’s first discovery to complete a pivotal Phase 3 clinical trial. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) belongs to Healthcare sector. Its weekly performance is 47.50%. On last trading day company shares ended up $12.67. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) distance from 50-day simple moving average (SMA50) is 52.96%.

Brookdale Senior Living Inc. (NYSE:BKD) reported Total revenue of $1.2 billion for the second quarter of 2015 was relatively flat compared with the first quarter of 2015, with resident fees declining $8.3 million. Average monthly revenue per unit for the consolidated senior housing portfolio was $4,331 in the second quarter of 2015, an increase of $26, or 0.6%, over the first quarter of 2015. Average occupancy for all consolidated communities for the second quarter of 2015 was 86.5%, compared to 87.4% for the first quarter of 2015. Brookdale Senior Living Inc. (NYSE:BKD) shares fell -7.15% in last trading session and ended the day at $30.66. BKD Gross Margin is 29.30% and its return on assets is -3.00%. Brookdale Senior Living Inc. (NYSE:BKD) quarterly performance is -15.12%.

Levi & Korsinsky has commenced an investigation into whether AAC Holdings, Inc. (NYSE:AAC) and certain of its officers and/or directors have violated federal securities laws. On July 29, 2015, AAC disclosed that the company and certain of its employees had been indicted on murder charges relating to the death of an AAC patient in 2010. Since then, several articles have highlighted instances of undisclosed deaths and distribution of controlled medications without prescriptions to patients allegedly at other AAC facilities. On 04 August, AAC Holdings, Inc. (NYSE:AAC) shares fell -39.34% and was closed at $19.89. AAC Holdings, Inc. (NYSE:AAC) year to date (YTD) performance is -35.67%.

Mallinckrodt plc (NYSE:MNK) swung to a net profit for the quarter ended Jun. 26, 2015. The company has made a net profit of $58 million, or $ 0.49 a share in the quarter, against a net loss of $24.10 million, or $0.41 a share in the last year period. Mallinckrodt PLC (NYSE:MNK) ended the last trading day at $106.73. Company weekly volatility is calculated as 5.88% and price to cash ratio as 11.85. Mallinckrodt PLC (NYSE:MNK) showed a weekly performance of -13.84%.

Endologix Inc. (NASDAQ:ELGX) reported Global revenue in the second quarter of 2015 was $39.5 million, a 3% increase from $38.3 million in the second quarter of 2014. For the six months ended June 30, 2015, global revenue increased 6% to $76.1 million, compared to $71.6 million for the six months ended June 30, 2014. On a constant currency basis, revenue for the second quarter and six months ended June 30, 2015 increased 8% and 11%, respectively. Endologix Inc. (NASDAQ:ELGX) shares fell -14.58% in last trading session and ended the day at $12.01. ELGX Gross Margin is 71.80% and its return on assets is -19.40%. Endologix Inc. (NASDAQ:ELGX) quarterly performance is -20.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *